11th Circ. Asked To Rehear Amgen, Pfizer Win In Enbrel Suit

Law360 (February 13, 2018, 9:18 PM EST) -- The Eleventh Circuit failed to consider several issues when it ruled in favor of Amgen Inc., Pfizer Inc. and Wyeth Inc. in a lawsuit brought by a woman claiming their arthritis drug, Enbrel, caused severe infections, according to a motion for rehearing filed Monday.

Rebecca Small, who has been litigating her case against the drugmakers with her husband, Lawrence, since 2012, said the panel’s mid-January decision affirming summary judgment for the companies failed to consider all of her arguments about whether her doctor knew enough to...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Rebecca Small, et al v. AMGN, et al


Case Number

17-11440

Court

Appellate - 11th Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

April 3, 2017

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.